Scientists from the First Moscow State Medical University named after IM. Sechenov, Ministry of Health of the Russian Federation, developed a program for remote determination of blood group: a healthcare worker will only need to upload a photo of a blood sample mixed with a reagent into the application. The digital product, which will enter the medical market within two years, will help minimize the risk of complications during blood transfusion. socialbites.ca was told about this at the university.
“Unfortunately, in our country, the problem of the lack of laboratory diagnostic doctors, who must confirm the results of the blood group analysis of potential recipients made by the attending physician, still persists. Thanks to our development, any healthcare worker will be able to send, via the application on the smartphone, a photo of a blood test mixed with reagent to a program that will prepare a preliminary result about the patient’s blood type. “The laboratory diagnostician will be able to confirm this result remotely by saving the analysis result and the image in the medical information system,” said Pavel Tregub, associate professor of the Department of Pathophysiology at Sechenov University and author of the PhotoResus software package. To socialbites.ca.
The digital service is based on artificial intelligence (AI) technology and will be available to healthcare staff via any smartphone. Using advanced image analysis algorithms, artificial intelligence determines the presence of agglutination (micro clots) in the blood after mixing it with a special reagent containing antibodies against red blood cells. Now these manipulations are carried out by a doctor who, with an expert eye, analyzes the adhesion of red blood cells in blood drops. But the capabilities of modern technologies make it possible to create a “digital analogue” of the eyes. The program has already attracted the interest of industrial partners; Scientists plan to introduce the product to the medical market within two years.
More than 1.5 million blood transfusions and their components are performed in Russia every year. Almost 30 thousand of them are accompanied by various complications associated with partial antigenic incompatibility of the donor and recipient according to various blood group classification systems, including rare. The developers of the software package are confident that in most cases these complications can be avoided. Their application will help eliminate the human factor and errors at various stages of analysis, as well as save on the purchase of equipment and consumables. This development will be especially relevant for surgical, obstetric-gynecological and obstetric departments in small and remote hospitals.
Previous scientists in the name A diet that reduces the risk of contracting coronavirus.